Optometrist and Johnson & Johnson professional affairs consultant, Faye McDearmid, shares her four steps to successful patient communication about presbyopia ...

Pharmacotherapy is the newest modality of presbyopia management, with the first agent (pilocarpine) gaining FDA approval for presbyopia in 2021. It offers a local, non-invasive, and reversible ...

The MarketWatch News Department was not involved in the creation of this content. The launch of emerging therapies, such as LNZ100 by Lenz Therapeutics, Phentolamine Ophthalmic Solution 0.75% by ...

Welcome to the health and wellness podcast. In this episode, we are joined by Irene Gitonga, an optometrist, to discuss the causes, symptoms, and treatment of presbyopia. Tune in to listen.

Tenpoint Therapeutics, Ltd., a global, commercial-stage ophthalmic pharmaceutical company focused on developing ...

Credit: Orasis Pharmaceuticals. The product is expected to be available in the first half of 2024. The Food and Drug Administration (FDA) has approved Qlosi ™ (pilocarpine hydrochloride ophthalmic ...

VIZZ is the first and only aceclidine-based eye drop approved to improve near vision in adults with presbyopia, a condition impacting approximately 128 million adults in the United States First once ...

Yuvezzi, an eye drop for the treatment of presbyopia, is now available in the U.S.

SAN DIEGO, Oct. 21, 2024 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (LENZ) (Nasdaq: LENZ or “LENZ” or the “Company”), a pre-commercial biopharmaceutical company focused on the development and ...